Last updated: Oct 9, 2026, 12:00 AM

Genmab AS Exchange (NASDAQ, USD)

GMAB

37.07
-1.15 (-3.04%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
10.03%
3 year return (CAGR)
2.29%
5 year return (CAGR)
-2.85%
10 year return (CAGR)
7.89%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
22.87B
Price/Sales
5.54
Ent value
27.93B
Price/Book
3.84
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
29.02
PEG
-
Forward P/E
23.95
EPS growth
6.29%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open37.30
Daily high37.86
Daily low36.27
Daily Volume4.25M
All-time high48.72
1y analyst estimate39.05
Beta0.70
EPS (TTM)1.28
Dividend per share0.00
Ex-div date-
Next earnings date17 Feb 2026

Ready to capitalize on Genmab AS's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
GMABS&P500
Current price drop from All-time high-23.91%-0.07%
Highest price drop-84.20%-56.47%
Date of highest drop8 Aug 20119 Mar 2009
Avg drop from high-22.06%-10.67%
Avg time to new high21 days12 days
Max time to new high1278 days1805 days